January 2023 updates to the website
18 January 2023
The website has now been updated following January's LSCMMG
The following guidelines have been added/updated:
LSCMMG ONS Guideline - Updated
Psoriasis Biologic Treatment Pathway - Updated
Olopatadine hydrochloride 600 micrograms / mometasone furoate monohydrate 25 micrograms per actuation nasal spray (Ryaltris®) - Updated
Delta-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) (Sativex®) For Refractory Neuropathic Pain - Updated
The following Items will be updated and added to the website following the next Pharmacy and Medicines Policy Task and Finish Group Meeting:
Degarelix for treatment of adult male patients with advanced hormone-dependent prostate cancer without spinal metastases